Amicogen China Biopharm

Amicogen China Biopharm, a subsidiary of the South Korean biotechnology leader Amicogen Inc., is a prominent manufacturer specializing in enzyme-driven pharmaceutical production and veterinary medicine. Based in Jining, China, the company was established following the acquisition of Shandong Lukang Shelile Pharmaceutical, integrating advanced protein engineering with large-scale fermentation capabilities. The company is a major global supplier of veterinary APIs such as Tylosin, Tilmicosin, and Tiamulin, as well as specialized enzymes used in the "green" synthesis of cephalosporin intermediates like 7-ACA and 7-ADCA. By replacing traditional chemical synthesis with biocatalysis, Amicogen China Biopharm focuses on reducing environmental impact and improving production efficiency in the life sciences sector. Their facilities are GMP-certified, supporting a robust business model that spans from R&D to international commercial distribution.